Five-day course of budesonide inhalation suspension is as effective as oral prednisolone in the treatment of mild to severe acute asthma exacerbations in adults.
Pulm Pharmacol Ther. 2011 Apr;24(2):256-60
Authors: Chian CF, Tsai CL, Wu CP, Chiang CH, Su WL, Chen CW, Perng WC
Limited evidence is available on the use of budesonide inhalation suspension (BIS) for the treatment of mild to severe acute asthma exacerbations (AAE) in adults in an inpatient setting. This study was conducted to evaluate the efficacy of a five-day course of BIS compared with oral prednisolone (OP) in the management of adults with AAE.
PMID: 20659578 [PubMed - indexed for MEDLINE]